Researchers evaluated the prevalence of pharmacologic osteoporosis prevention among nursing home residents and assessed its association with patient characteristics.
Researchers determined whether balance and functional mobility predicted bone mineral density in postmenopausal women with osteoporosis and osteopenia.
For women who have received five years of bisphosphonate therapy, hip fracture risk does not differ with continuing treatment for an additional five years.